Your browser doesn't support javascript.
loading
Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.
Pasquini, Marcelo C; Zhang, Mei-Jie; Medeiros, Bruno C; Armand, Philippe; Hu, Zhen-Huan; Nishihori, Taiga; Aljurf, Mahmoud D; Akpek, Görgün; Cahn, Jean-Yves; Cairo, Mitchell S; Cerny, Jan; Copelan, Edward A; Deol, Abhinav; Freytes, César O; Gale, Robert Peter; Ganguly, Siddhartha; George, Biju; Gupta, Vikas; Hale, Gregory A; Kamble, Rammurti T; Klumpp, Thomas R; Lazarus, Hillard M; Luger, Selina M; Liesveld, Jane L; Litzow, Mark R; Marks, David I; Martino, Rodrigo; Norkin, Maxim; Olsson, Richard F; Oran, Betul; Pawarode, Attaphol; Pulsipher, Michael A; Ramanathan, Muthalagu; Reshef, Ran; Saad, Ayman A; Saber, Wael; Savani, Bipin N; Schouten, Harry C; Ringdén, Olle; Tallman, Martin S; Uy, Geoffrey L; Wood, William A; Wirk, Baldeep; Pérez, Waleska S; Batiwalla, Minoo; Weisdorf, Daniel J.
Afiliação
  • Pasquini MC; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: mpasquini@mcw.edu.
  • Zhang MJ; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Medeiros BC; Department of Hematology, Stanford University School of Medicine, Stanford, California.
  • Armand P; Department of Medical Oncology/Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hu ZH; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Nishihori T; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Aljurf MD; Department of Oncology, King Faisal Specialist Hospital Center and Research, Riyadh, Saudi Arabia.
  • Akpek G; Stem Cell Transplantation and Cellular Therapy Program, Banner MD Anderson Cancer Center, Gilbert, Arizona.
  • Cahn JY; Department of Hematology, University Hospital, Grenoble, France.
  • Cairo MS; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, New York.
  • Cerny J; Department of Medicine, UMass Memorial Medical Center, Worcester, Massachusetts.
  • Copelan EA; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.
  • Deol A; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.
  • Freytes CO; Division of Hematology & Oncology, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio, Texas.
  • Gale RP; Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom.
  • Ganguly S; Blood and Marrow Transplantation, Division of Hematology and Oncology, University of Kansas Medical Center, Kansas City, Kansas.
  • George B; Department of Haematology, Christian Medical College, Vellore, India.
  • Gupta V; Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Hale GA; Department of Hematology/Oncology, All Children's Hospital, St. Petersburg, Florida.
  • Kamble RT; Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.
  • Klumpp TR; Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
  • Lazarus HM; Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, Ohio.
  • Luger SM; Department of Medicine, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania.
  • Liesveld JL; Department of Medicine, University of Rochester Medical Center, Rochester, New York.
  • Litzow MR; Division of Hematology and Transplant Center, Mayo Clinic, Rochester, Minnesota.
  • Marks DI; Pediatric Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, United Kingdom.
  • Martino R; Division of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Norkin M; Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, Florida.
  • Olsson RF; Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden.
  • Oran B; Division of Cancer Medicine, Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pawarode A; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
  • Pulsipher MA; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California.
  • Ramanathan M; Department of Medicine, UMass Memorial Medical Center, Worcester, Massachusetts.
  • Reshef R; Department of Medicine, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania.
  • Saad AA; Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Saber W; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Schouten HC; Department of Hematology, Academische Ziekenhuis, Maastricht, Netherlands.
  • Ringdén O; Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for Allogeneic Stem Cell Transplantation, Stockholm, Sweden.
  • Tallman MS; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Uy GL; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Wood WA; Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina.
  • Wirk B; Division of Bone Marrow Transplant, Seattle Cancer Care Alliance, Seattle, Washington.
  • Pérez WS; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Batiwalla M; Hematology Branch, National Heart Lung and Blood Institute - National Institutes of Health, Bethesda, Maryland.
  • Weisdorf DJ; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota.
Biol Blood Marrow Transplant ; 22(2): 248-257, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26327629

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_muertes_prevenibles Assunto principal: Síndromes Mielodisplásicas / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_muertes_prevenibles Assunto principal: Síndromes Mielodisplásicas / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2016 Tipo de documento: Article
...